Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination Taken Orally for 8 Weeks in Adult Subjects With Essential Hypertension Who Are Inadequately Controlled on 16 mg Candesartan Cilexetil Monotherapy
Conditions
Interventions
Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)
Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)
+4 more
Locations
8
Italy
Fondazione Università G.D'Annunzio
Chieti, Abruzzo, Italy
A.O.U. di Bologna Policlinico S.Orsola Malpighi
Bologna, Emilia-Romagna, Italy
AAS 3 Friuli Alto Medio Collin
Udine, Friuli Venezia Giulia, Italy
Fondazione Salvatore Maugeri
Pavia, Lombardy, Italy
IRCCS Ist Neurologico Mediterraneo
Isernia, Molise, Italy
A.O.U. di Sassari
Sassari, Sardinia, Italy
Start Date
December 1, 2017
Primary Completion Date
December 8, 2019
Completion Date
December 8, 2019
Last Updated
May 22, 2017
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Bayer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions